In a case series, Guadiana et al. [222], while evaluating the potential role of GDF15 in predicting in-hospital mortality during COVID-19, observed that serum levels of this biomarker increased in patients who died during the hospital stay. This evidence concerns the gene GDF15 and COVID-19.